BTEK.L vs. BRK-B
Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Berkshire Hathaway Inc. (BRK-B).
BTEK.L is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Oct 19, 2017.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BTEK.L or BRK-B.
Key characteristics
BTEK.L | BRK-B | |
---|---|---|
YTD Return | 1.02% | 15.02% |
1Y Return | 3.42% | 26.80% |
3Y Return (Ann) | 2.07% | 12.20% |
5Y Return (Ann) | 6.59% | 14.96% |
Sharpe Ratio | 0.35 | 2.25 |
Daily Std Dev | 15.01% | 12.08% |
Max Drawdown | -30.86% | -53.86% |
Current Drawdown | -10.61% | -2.44% |
Correlation
The correlation between BTEK.L and BRK-B is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BTEK.L vs. BRK-B - Performance Comparison
In the year-to-date period, BTEK.L achieves a 1.02% return, which is significantly lower than BRK-B's 15.02% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BTEK.L vs. BRK-B - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BTEK.L vs. BRK-B - Dividend Comparison
Neither BTEK.L nor BRK-B has paid dividends to shareholders.
Drawdowns
BTEK.L vs. BRK-B - Drawdown Comparison
The maximum BTEK.L drawdown since its inception was -30.86%, smaller than the maximum BRK-B drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for BTEK.L and BRK-B. For additional features, visit the drawdowns tool.
Volatility
BTEK.L vs. BRK-B - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) has a higher volatility of 4.92% compared to Berkshire Hathaway Inc. (BRK-B) at 2.92%. This indicates that BTEK.L's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.